Overview
Status
Active
Registry date
2015-05-20
Share capital
550,000.00 PLN
Registered address
ul. Jutrzenki 137A, 02-231 Warszawa, Poland
Electronic delivery address
AE:PL-48197-10419-FCVBC-21
Financials
Revenue history (in m)
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 63 days for 2025). All were audited by a statutory auditor.
- 202516/09/2026
- 202406/08/2025
- 202326/06/2024
- 202213/06/2023
- 202109/09/2022
- 202015/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 14.09mMedianUSD 1.06mAverageUSD 22.40m
Net profit
This companyUSD 77.24kMedianUSD 37.33kAverageUSD 880.24k
Operating costs
This companyUSD 13.77mMedianUSD 922.77kAverageUSD 21.08m
Assets
This companyUSD 6.92mMedianUSD 608.93kAverageUSD 11.85m
Industry
Public procurement
94 tenders recorded as contractor: 40 national ($2,724,501) and 54 EU ($14,981,333).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 26, 2026 | SZP.281.23.2026 – Supply of reagent kits and culture media, with equipment rental, for conducting tests for Instytut „CZMP” | $997.3K$997,332 | Instytut Centrum Zdrowia Matki Polki | |
| Oct 20, 2026 | Supply of reagents together with the lease of analysers | $104.5K$104,539 | Narodowy Instytut Geriatrii,Reumatologii I Rehabilitacji Im. Prof. Dr Hab. Med. Eleonory Reicher | |
| Sep 30, 2026 | Successive supply of antibodies and reagents for cytometric diagnostics, as well as reagents and consumables for the liaison XL analyzer owned, including lease of a backup analyzer, for Narodowy Instytut Onkologii im. Marii Skłodowskiej – Curie - Państwowy Instytut Badawczy, Oddział w Gliwicach | $165.4K$165,396 | Narodowy Instytut Onkologii Im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy Oddział w Gliwicach |
Authorized Representatives
Thomas Doll – Management Board Member
Ewa Kluck Sztyma – Attorney-in-fact (sole)
Valerio Giovanni Vaccarone – Management Board Member
Thorsten Hilbich – Management Board Member
Manner of representation
Each member of the management board is authorised to represent the company, make declarations and sign on behalf of the company, acting independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Diasorin S.p.a. | 11,000 | $148,568.34 | 100% |
Bank accounts
Registered as a VAT taxpayer on 2015-04-20.
93 1880 0009 0000 0011 0257 6000
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Synkmedsp. z o.o. | $20,634,200.47 | synkmed.pl | ||
| Intimexsp. z o.o. + limited partnership | $18,994,512.90 | intimex.com.pl | ||
| Ivoclar-Vivadent Polskasp. z o.o. | $17,154,419.26 | ivoclar.com | ||
| AO East Europesp. z o.o. | $13,998,610.57 | aoeasteurope.pl | ||
| PolypharmS.A. | $13,660,727.48 | polypharm.pl | ||
| Medif sp. z o.o.sp. k. | $13,126,958.83 | medif.com | ||
| PromedS.A. | $12,643,674.56 | promed.com.pl | ||
| MassmedicaS.A. | $8,216,274.00 | massmedica.com | ||
| Billmedsp. z o.o. | $5,738,714.60 | e.pl | ||
| SPA Landsp. z o.o. | $4,782,973.66 | hydrafacial.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-04-07 | PKD change (Removed: 46.69.Z, 47.99.Z, 95.11.Z; Added: 46.64.Z, 47.78.Z, 95.10.Z) | |
| 2020-07-02 | PKD change (Added: 33.12.Z, 33.20.Z, 46.69.Z, 77.39.Z, 95.11.Z) | |
| 2015-11-13 | Share capital increase (500,000.00 PLN → 550,000.00 PLN) | |
| 2015-07-28 | Address change (Al. Aleje Jerozolimskie 56c, 00-803, Warszawa → Ul. Jutrzenki 137a, 02-231, Warszawa) | |
| 2015-07-28 | Share capital increase (5,000.00 PLN → 500,000.00 PLN) |
FAQ
Last updated: 2026-10-07